9
Revealed: obesity jab maker discussed targeting benefit claimants with UK government
(www.theguardian.com)
this post was submitted on 18 Nov 2023
9 points (100.0% liked)
United Kingdom
4068 readers
502 users here now
General community for news/discussion in the UK.
Less serious posts should go in [email protected] or [email protected]
More serious politics should go in [email protected].
Try not to spam the same link to multiple feddit.uk communities.
Pick the most appropriate, and put it there.
Posts should be related to UK-centric news, and should be either a link to a reputable source, or a text post on this community.
Opinion pieces are also allowed, provided they are not misleading/misrepresented/drivel, and have proper sources.
If you think "reputable news source" needs some definition, by all means start a meta thread.
Posts should be manually submitted, not by bot. Link titles should not be editorialised.
Disappointing comments will generally be left to fester in ratio, outright horrible comments will be removed.
Message the mods if you feel something really should be removed, or if a user seems to have a pattern of awful comments.
founded 1 year ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
This is the best summary I could come up with:
Internal documents obtained by the Observer reveal that Pinder Sahota, corporate vice-president of Novo Nordisk UK, told the then health secretary Steve Barclay, England’s chief medical officer and Treasury officials that “data from the Department for Work and Pensions [DWP] could help profile those who are most likely to return to the labour market”.
During the meeting, attendees discussed the potential socioeconomic benefits of making weight-loss injections available in a community-based pilot scheme alongside “wraparound support”, such as back-to-work counselling.
In March, the Times reported that “millions of people could be offered a new generation of weight-loss drugs under plans to turn the tide on obesity and get benefit claimants back to work”, after an apparent briefing by officials.
A joint announcement from the prime minister and the Department of Health in June 2023 said that potential effects of the pilot included cutting NHS waiting lists and “wider economic benefits”.
Prof Simon Capewell, a public health policy expert and emeritus professor at Liverpool University, said the comments by Novo Nordisk executives were “shocking and “absolutely unethical”.
Labour MP Debbie Abrahams, co-chair of the all-party parliamentary group on universal credit and a member of the Work and Pensions Committee, said the suggestion from Novo Nordisk to target benefit claimants was “very worrying on several levels”.
The original article contains 1,287 words, the summary contains 214 words. Saved 83%. I'm a bot and I'm open source!